Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients.

Butrym A, Majewski M, Dzietczenia J, Kuliczkowski K, Mazur G.

Leuk Res. 2012 Jul;36(7):876-80. doi: 10.1016/j.leukres.2012.01.017. Epub 2012 Feb 12.

PMID:
22333038
2.

HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses.

Scielzo C, Ghia P, Conti A, Bachi A, Guida G, Geuna M, Alessio M, Caligaris-Cappio F.

J Clin Invest. 2005 Jun;115(6):1644-50.

3.

HS1, a Lyn kinase substrate, is abnormally expressed in B-chronic lymphocytic leukemia and correlates with response to fludarabine-based regimen.

Frezzato F, Gattazzo C, Martini V, Trimarco V, Teramo A, Carraro S, Cabrelle A, Ave E, Facco M, Zambello R, Tibaldi E, Brunati AM, Semenzato G, Trentin L.

PLoS One. 2012;7(6):e39902. doi: 10.1371/journal.pone.0039902. Epub 2012 Jun 29.

4.

MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.

Zhou K, Yi S, Yu Z, Li Z, Wang Y, Zou D, Qi J, Zhao Y, Qiu L.

Leuk Lymphoma. 2012 Jun;53(6):1155-61. doi: 10.3109/10428194.2011.642303. Epub 2012 Jan 31.

PMID:
22145958
5.

CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia.

Buhl AM, Jurlander J, Geisler CH, Pedersen LB, Andersen MK, Josefsson P, Petersen JH, Leffers H.

Eur J Haematol. 2006 Jun;76(6):455-64. Epub 2006 Mar 9.

PMID:
16529606
6.

CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia.

Xu W, Li JY, Wu YJ, Yu H, Shen QD, Tian T, Li L, Qiu HX.

Leuk Res. 2009 Feb;33(2):237-43. doi: 10.1016/j.leukres.2008.06.026. Epub 2008 Jul 31.

PMID:
18674817
7.

HS1 has a central role in the trafficking and homing of leukemic B cells.

Scielzo C, Bertilaccio MT, Simonetti G, Dagklis A, ten Hacken E, Fazi C, Muzio M, Caiolfa V, Kitamura D, Restuccia U, Bachi A, Rocchi M, Ponzoni M, Ghia P, Caligaris-Cappio F.

Blood. 2010 Nov 4;116(18):3537-46. doi: 10.1182/blood-2009-12-258814. Epub 2010 Jun 8.

8.

The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells.

Ocaña E, Delgado-Pérez L, Campos-Caro A, Muñóz J, Paz A, Franco R, Brieva JA.

Haematologica. 2007 Mar;92(3):349-56.

9.

Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.

Moshynska O, Sankaran K, Pahwa P, Saxena A.

J Natl Cancer Inst. 2004 May 5;96(9):673-82.

10.

[Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].

Kardum-Skelin I, Planinc-Peraica A, Ostojić Kolonić S, Radić-Kristo D, Milas M, Vrhovac R, Sustercić D, Minigo H, Jaksić B.

Acta Med Croatica. 2008 Oct;62(4):351-64. Croatian.

PMID:
19205412
11.

Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia.

ten Hacken E, Scielzo C, Bertilaccio MT, Scarfò L, Apollonio B, Barbaglio F, Stamatopoulos K, Ponzoni M, Ghia P, Caligaris-Cappio F.

Blood. 2013 Mar 21;121(12):2264-73. doi: 10.1182/blood-2012-09-457119. Epub 2013 Jan 16.

12.

Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.

Molica S, Vitelli G, Mirabelli R, Digiesu G, Giannarelli D, Cuneo A, Ribatti D, Vacca A.

Eur J Haematol. 2006 Jan;76(1):51-7.

PMID:
16343271
13.

The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia.

Chen L, Li J, Zheng W, Zhang Y, Wu Y, Li L, Qian S, Xu W.

Leuk Lymphoma. 2007 Sep;48(9):1785-92.

PMID:
17786715
14.

CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.

Domingo-Domènech E, Domingo-Clarós A, Gonzàlez-Barca E, Beneitez D, Alonso E, Romagosa V, De Sanjos S, Petit J, Grañena A, Fernández de Sevilla A.

Haematologica. 2002 Oct;87(10):1021-7.

15.

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marcé S, López-Guillermo A, Campo E, Montserrat E.

N Engl J Med. 2003 May 1;348(18):1764-75.

16.

High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.

Wolowiec D, Wojtowicz M, Ciszak L, Kosmaczewska A, Frydecka I, Potoczek S, Urbaniak-Kujda D, Kapelko-Slowik K, Kuliczkowski K.

Eur J Haematol. 2009 Apr;82(4):260-6. doi: 10.1111/j.1600-0609.2008.01196.x. Epub 2009 Jan 6.

PMID:
19187271
17.

Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.

Gachard N, Salviat A, Boutet C, Arnoulet C, Durrieu F, Lenormand B, Leprêtre S, Olschwang S, Jardin F, Lafage-Pochitaloff M, Penther D, Sainty D, Reminieras L, Feuillard J, Béné MC; GEIL.

Haematologica. 2008 Feb;93(2):215-23. doi: 10.3324/haematol.11622. Epub 2008 Jan 26.

18.

Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.

Ibrahim S, Jilani I, O'Brien S, Rogers A, Manshouri T, Giles F, Faderl S, Thomas D, Kantarjian H, Keating M, Albitar M.

Cancer. 2003 Apr 15;97(8):1914-9.

19.

Clinical significance of CD38 expression in chronic lymphocytic leukemia.

Del Poeta G, Maurillo L, Venditti A, Buccisano F, Epiceno AM, Capelli G, Tamburini A, Suppo G, Battaglia A, Del Principe MI, Del Moro B, Masi M, Amadori S.

Blood. 2001 Nov 1;98(9):2633-9.

20.

Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.

Gattei V, Bulian P, Del Principe MI, Zucchetto A, Maurillo L, Buccisano F, Bomben R, Dal-Bo M, Luciano F, Rossi FM, Degan M, Amadori S, Del Poeta G.

Blood. 2008 Jan 15;111(2):865-73. Epub 2007 Oct 24.

Items per page

Supplemental Content

Write to the Help Desk